Trial drug may block early stages of COVID-19, study in human cells shows
A drug already tested against lung disease could potentially inhibit COVID-19 by reducing the coronavirus load that enters the lungs and other organs. That is according to a study in human cell cultures and organoids by researchers at Karolinska Institutet in Sweden and the University of British Columbia (UBC) in Canada, published in the journal Cell.The results could be promising for the treatment of COVID-19 patients who are in the early stages of infection, according to the researchers. “Our study provides new insights into how SARS-CoV-2 infects the cells of the body, including in